Previous Close | 14.05 |
Open | 13.98 |
Bid | 13.96 x 2200 |
Ask | 13.96 x 3200 |
Day's Range | 13.70 - 14.14 |
52 Week Range | 7.09 - 14.47 |
Volume | |
Avg. Volume | 9,279,165 |
Market Cap | 15.834B |
Beta (5Y Monthly) | 1.06 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.50 |
Earnings Date | May 08, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | Nov 27, 2017 |
1y Target Est | 15.50 |
TEL AVIV, Israel, May 02, 2024--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today published its 2023 Healthy Future Report, sharing its actions to promote healthy people, a healthy planet and a healthy business. The report unveils new targets to achieve net zero emissions across Teva’s operations and value chain by 2045 and 100% renewable electricity across all Teva sites by 2035, as well as to reach 200% more total beneficiaries of health system strengthening and capacity building
Q1 2024 Corcept Therapeutics Inc Earnings Call
Corcept reports a robust financial performance and advances in clinical trials, despite facing potential generic competition.